Arcutis - M&A Summary and Business Overview

Life ScienceCompany

Arcutis M&A Summary

Arcutis has acquired 1 company, including 1 in the last 5 years.

Arcutis’ largest acquisition to date was in 2022, when it acquired Ducentis BioTherapeutics for $16M. The Company’s most targeted sectors include life science (100%).

Arcutis Business Overview

Where is Arcutis headquartered?

Arcutis is headquartered in Westlake Village, California.

What is Arcutis’ revenue?

Arcutis disclosed revenue of 60M USD for 2023 and 4M USD for 2022.

How many employees does Arcutis have?

Arcutis has 296 employees.

What sector is Arcutis in?

Arcutis is a life science company.

When was Arcutis founded?

Arcutis was founded in 2016.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Advisors 1

Arcutis

Arcutis Biotherapeutics, Inc.

3027 Townsgate Road, Suite 300,
Westlake Village, California 91361
United States,
(805) 418-5006
www.arcutis.com

Arcutis is focused on developing topical medicines for the treatment of skin diseases. The company’s lead program, ARQ-151, is a topical formulation of roflumilast that is currently in Phase 2 studies for the treatment of plaque psoriasis and atopic dermatitis. The company’s second program, ARQ-250, is a topical JAK1-inhibitor in preclinical development for the treatment of various autoimmune diseases affecting the skin. Arcutis was founded in 2016 and is based in Westlake Village, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # - - - 1 - - 1
vol $16M $16M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Ducentis BioTherapeutics Ltd. 2022-09-07 16M USD Add-on Acquisition
Oxfordshire, United Kingdom · www.ducentisbio.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 16M (100%) - -
Total 1 $16M - -

By Geo

State/Country Buy Value Sell Value
United Kingdom 1 16M - -
Total 1 $16M - -

Top M&A Advisors

Legal Deals
Covington & Burling
1

Deal Values

buy # Total
< $100M 1 $16M
TOTAL $16M
Largest Ducentis BioTherapeutics Ltd.
$16M (2022-09-07)

 Subscribe to unlock this and 207,692
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.